Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	70263	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	81618	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	88676	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	107173	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	111845	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	112316	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	117402	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	130423	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	139646	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	146719	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	150192	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	157089	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	161389	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	163875	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	171837	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	174743	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	182060	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	184958	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	187412	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	193578	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	194181	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	201249	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	201457	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	206263	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	211237	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	215021	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	215090	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	222865	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	226044	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	237700	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	242409	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	246376	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	248939	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	249380	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	254054	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	257295	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	259624	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	259650	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	259762	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	261541	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	265684	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	269830	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	270804	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	271215	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	273404	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	280930	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	286126	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	292437	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	294998	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	295832	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	296673	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	311196	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	321276	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	324803	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	326628	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	329860	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	335485	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	342200	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	354593	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	354962	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	355353	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	356139	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	356630	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	358185	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	365474	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	379563	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	393195	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	396774	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	400831	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	415921	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	416748	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	417510	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	427337	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	449992	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	451325	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	459232	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	465593	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	472065	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	475718	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	484745	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	494119	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	505270	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	505353	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	509452	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	513075	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	514976	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	522984	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	569037	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	570456	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	582782	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	584836	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	597009	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	626874	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	641606	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	649143	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	664445	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	694099	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	843656	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	880132	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M+CL)-	2090764	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	8061	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	10380	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	12848	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	14134	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	15581	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	16244	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	17840	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	19873	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	20164	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	21138	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	21258	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	21353	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	21795	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	22344	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	22811	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	23556	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	24021	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	24893	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	25136	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	25159	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	25485	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	25634	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	26721	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27109	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27227	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27285	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27577	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27710	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27728	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	27898	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	28501	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	28868	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29337	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29373	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29674	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29767	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29796	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29803	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	29863	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	31689	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	32261	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	32779	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	33504	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	35193	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	35609	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	35692	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	36420	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	36767	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	37184	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	37207	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	37515	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	38057	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	38836	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	39535	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	39682	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	41022	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	41157	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	41370	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	41372	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	41790	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	42307	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	42916	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	42957	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	43149	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	43796	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	44495	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	44587	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	45148	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	45602	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	45639	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	46697	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	46714	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	46935	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	47815	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	48454	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	49435	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	49711	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	50239	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	50711	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	50811	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	52983	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	53629	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	53746	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	56274	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	56275	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	56397	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	56570	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	57733	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	58693	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	58798	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	60632	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	61341	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	62010	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	62592	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	67058	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	74677	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	74842	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	83353	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	86599	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URIDINE (CAS# 58-96-8); (M-H)-	175569	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y

Return to search page